Skip to Main Content
March 8, 2024
Health Law Weekly

Featured Articles

Dissecting Recent Cybersecurity Regulatory Moves at the Federal and State Levels

Integrating Mifepristone into Big Pharmacy: Considerations for Continued Expansion to Access and Data Privacy Concerns

  • Natalie Birnbaum, Founding Attorney at Repro Solutions PC, State Legal and Policy Director at RHITES (Reproductive Healthcare Initiative for Telehealth Equity and Solutions)

Top Ten 2024: Tracking Technology Remediation, Litigation, and Enforcement

Current Topics

Antitrust

DOJ, FTC, HHS Launch Probe of Private Equity Health Care Deals

Fraud and Compliance

Fraudster Pleads Guilty in Telemedicine DME Fraud Scheme

Husband and Wife Sentenced to over Two Years Each for Medicare, Tricare Fraud Schemes

Physician Agrees to $60k Settlement of Fraud Allegations over Opioid Prescribing

Physician Pleads Guilty to Health Care Fraud

Physician, Employee Convicted in Kickback Scheme

Precision Lens Appealing $217 Million Judgment in FCA Action

Government Reimbursement

Drug Manufacturers Send Counteroffers as Medicare Price Negotiations Continue, HHS Says

Fourth Circuit Again Rejects South Carolina’s Bid to Exclude Planned Parenthood from Medicaid

U.S. Court in Delaware Nixes AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program

Health Information

HHS Responds to Change Healthcare Cyberattack; UnitedHealth Offers Timelines for Restoring Systems

Health Policy and Administration

Biden Lays out Health Care Agenda in State of the Union Address

Congress Agrees to Partial Spending Package with Medicare Pay Bump for Physicians

Life Sciences

FDA Offers Draft Guidance on Presenting “Key Information” for Informed Consent

Long Term Care

House Ways and Means Approves Measure to Block Minimum Staffing Mandate for Nursing Homes

Patient Care Liability and Litigation

U.S. Court in Louisiana Says Material Facts Remain Regarding Appropriateness of Patient Screening

Reproductive Health Law Hub

Alabama Enacts Legislation to Protect IVF After State Supreme Court Ruling

First OTC Birth Control Pill Set to Hit Shelves with $19.99/Month Suggested Price
Current Issue
Health Law Weekly Issue - March 8, 2024